David A. Siegel Agios Pharmaceuticals, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 20,900 shares of AGIO stock, worth $892,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,900Holding current value
$892,430% of portfolio
0.0%Shares
18 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$239 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$199 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$171 Million1.84% of portfolio
-
State Street Corp Boston, MA3.14MShares$134 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.34B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...